Profit In The Time of Pandemic: How Big Pharma benefitted from the COVID-19 crisis, and why the TRIPS Agreement should be scrapped

The world is in dire need of vaccines. Close to two years into the coronavirus crisis, the global death toll has reached 5 million. Deaths are feared to be higher than recorded. Despite expedited development of vaccines for COVID-19, access to them remains limited, especially for low and middle-income countries. The monopoly of big pharmaceutical companies over vaccine production and supply hampers access among  poorer nations. More lives are lost, when vaccines could have saved them.

Download here: []

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *